Products that can prove their efficacy in treating smoking addiction can pursue a medical licence route in the UK. The MHRA, Britain’s pharmaceutical regulator, is currently encouraging and supporting companies to submit medicines authorisation applications for e-cigarette products.
This route offers both advantages and disadvantages. Though quite costly and time-consuming, it enables producers and sellers to make health claims and sidestep product restrictions imposed on tobacco-related e-cigarette products.
This regulatory report from ECigIntelligence explains how the process works, and examines the pros and cons.